157 related articles for article (PubMed ID: 12828326)
1. Toxic epidermal necrolysis after topical intranasal application of mupirocin.
Praz SM; de Torrenté A; Zender H; Schmied E; Schleppy CA; Genné D
Infect Control Hosp Epidemiol; 2003 Jun; 24(6):459-60. PubMed ID: 12828326
[TBL] [Abstract][Full Text] [Related]
2. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of mupirocin in eradicating methicillin-resistant Staphylococcus aureus from nasal discharge in carrying cardiovascular surgical patients].
Soga Y; Okabayashi H; Shimada I; Enomoto S; Morimoto T; Kamikawa Y; Saito Y; Matsubayashi K; Nagasawa A
Kyobu Geka; 1999 Aug; 52(9):735-8. PubMed ID: 10453162
[TBL] [Abstract][Full Text] [Related]
4. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
Semret M; Miller MA
Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.
Solares CA; Batra PS; Hall GS; Citardi MJ
Am J Otolaryngol; 2006; 27(3):161-5. PubMed ID: 16647979
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery.
Cunha BA; Thekkel V; Schoch P; Cosgrove L
Am J Infect Control; 2011 Apr; 39(3):243-6. PubMed ID: 21145622
[TBL] [Abstract][Full Text] [Related]
7. Incidence and effect of incorrect prescription and administration of nasal mupirocin for methicillin-resistant Staphylococcus aureus.
Lines LD; Weightman NC
J Hosp Infect; 2005 Oct; 61(2):179-80. PubMed ID: 16002185
[No Abstract] [Full Text] [Related]
8. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Wertheim HF; Vos MC
Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
[TBL] [Abstract][Full Text] [Related]
9. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
10. Apples, oranges, and methicillin-resistant Staphylococcus aureus.
Dzubow L
Dermatol Surg; 2010 Oct; 36(10):1541-3. PubMed ID: 20698868
[No Abstract] [Full Text] [Related]
11. Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward.
Mori N; Hitomi S; Nakajima J; Okuzumi K; Murakami A; Kimura S
J Infect Chemother; 2005 Oct; 11(5):231-3. PubMed ID: 16258818
[TBL] [Abstract][Full Text] [Related]
12. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
13. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.
Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Kobayashi S; Sato A; Sugita R; Nagatake T
J Clin Microbiol; 2001 Oct; 39(10):3775-7. PubMed ID: 11574616
[TBL] [Abstract][Full Text] [Related]
14. Agents for the decolonization of methicillin-resistant Staphylococcus aureus.
McConeghy KW; Mikolich DJ; LaPlante KL
Pharmacotherapy; 2009 Mar; 29(3):263-80. PubMed ID: 19249946
[TBL] [Abstract][Full Text] [Related]
15. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
[TBL] [Abstract][Full Text] [Related]
16. Effect of intranasal mupirocin and chlorhexidine body wash on decolonization of community-associated methicillin-resistant Staphylococcus aureus.
Leung YH; Wong MM; Chuang SK
Infect Control Hosp Epidemiol; 2011 Oct; 32(10):1048-50. PubMed ID: 21931262
[No Abstract] [Full Text] [Related]
17. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
18. Drug utilization review of mupirocin ointment in a Korean university-affiliated hospital.
Youn SH; Lee SS; Kim S; Lee JA; Kim BJ; Kim J; Han HK; Kim JS
Korean J Intern Med; 2015 Jul; 30(4):515-20. PubMed ID: 26161018
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery.
Suzuki Y; Kamigaki T; Fujino Y; Tominaga M; Ku Y; Kuroda Y
Br J Surg; 2003 Sep; 90(9):1072-5. PubMed ID: 12945073
[TBL] [Abstract][Full Text] [Related]
20. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?
Walker ES; Vasquez JE; Dula R; Bullock H; Sarubbi FA
Infect Control Hosp Epidemiol; 2003 May; 24(5):342-6. PubMed ID: 12785407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
